article thumbnail

Eugia Pharma -Walk-In Interviews for Production/ Warehouse / Quality Assurance/ Quality Control/ Microbiology On 24th Sept’ 2022

Pharma Pathway

Eugia Pharma Specialities Limited is Subsidiary of Aurobindo Pharma Limited, Aurobindo Pharma Ltd’ (APL). Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations. Job Description. Email Id: hariprasad.vadlamuri@aurobindo.com / harikrishna.gottumukkala@eugia.co.in.

Pharma 86
article thumbnail

Medicinal cannabis: the route to good manufacturing practice registration

European Pharmaceutical Review

After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. How do you see the evolution of cannabis-based medicines, particularly when it comes to the ‘specials’ or fully licensed drug routes? He founded Celadon in 2018.

Medicine 128
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Mainland China’s regulatory evolution brings greater access to novel drugs

Clarivate

In parallel, the CDE also established a special channel to facilitate these approvals. Despite the availability of multiple DMTs in the Western markets, there was a dearth of DMTs in Mainland China before 2018. 2] Opinion on the list of new drugs marketed overseas urgently needed in China , August 2018. [3]

article thumbnail

mRNA therapeutics: a limitless revolution in medicine

European Pharmaceutical Review

Targeted entry of mRNA into human cells is a challenging process that requires special delivery systems to protect the therapeutic mRNA from degradation…”. The first drug to be approved with an ionised lipid was Onpattro® (patisiran) for the treatment of hereditary transthyretin protein amyloidosis in 2018. Boisguérin P, et a l.

Medicine 105
article thumbnail

For rare disease patients in Mainland China, hope of greater access to treatment

Clarivate

6] [7] However, in May 2018, the National Health Commission of China (NHC), together with four other national agencies, formulated China’s First List of Rare Diseases (CRDL) to provide a foundation for policymaking around rare disease treatments. 2018; 40:432-434. (in Source: Clarivate analysis. 10] [11] [12]. 10] [11] [12].

article thumbnail

Healthcare Watch September 2022

PM360

In many of the states where abortion is banned, strictly regulated, or soon to be restricted, the procedure is legal only in instances of a life-threatening situation, but no regulations define what such a situation may be, leaving 70% of physicians unclear about when to intervene for maternal safety. Med Device Approvals.

article thumbnail

Top Considerations for Data Protection and Cybersecurity within the Pharmaceutical Industry

Pharma Marketing Network

For companies that process “special categorizes of data, through research and clinical trials etc.,” The GDPR requires any company that processes large amounts of special categories of personal data to appoint a data protection officer , either by recruitment of a new employee or via an outsourced data protection officer.